Predictors of survival in idiopathic interstitial pneumonia

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 8, 2010, Pages 695-704

  Carbone, R ^a   Bottino, G ^b   Paredi, P ^c   Shah, P ^c   Meyer, Keith C ^d  

^a Regional Hospital Aosta   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Age; Idiopathic interstitial pneumonia; Idiopathic pulmonary fibrosis; Non specific interstitial pneumonia; Octreotide; Prognostic factors; Pulmonary artery pressure; Survival

Indexed keywords

PENTETREOTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; SOMATOSTATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE CLASSIFICATION; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; AGE; INTERSTITIAL LUNG DISEASE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; INDIUM RADIOISOTOPES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SOMATOSTATIN; SURVIVAL ANALYSIS;

EID: 77955928591     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. HUNNINGHAKE GW, SCHWARTZ MI State of the art. Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? The Proceedings of the American Thoracic Society 2007; 4: 449-452.
2. CARBONE R, BALLEARI E, GROSSO M, MONTANARO F, BOTTINO G, GHIO R. Predictors of mortality of idiopathic pulmonary fibrosis. Eur Rev Med Pharmacol Sci 2008; 12: 97-104.
3. G. GRIBBIN J, HUBBARD RB, LE JEUNE I, SMITH O, WEST J, TATA LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985. (Pubitemid 44787169)
4. MELTZER EB, NOBLE PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008; 26: 3-8.
5. MEYER KC, RAGHU G. Idiopathic pulmonary fibrosis and associated pulmonary hypertension: genetics, pathobiology, diagnosis, and management. In: Baughman RP, Carbone RG, Bottino G. (eds.) Pulmonary Arterial Hypertension and Interstitial Lung Diseases. New York: Springer 2009; pp. 51-69.
6. JEGAL Y, KIM DS, SHIM TS, LIM CM, DO LEE S, KOH Y, KIM WS, KIM WD, LEE JS, TRAVIS WD, KITAICHI M, COLBY TV. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 639-644.
7. AMERICAN THORACIC SOCIETY, EUROPEAN RESPIRATORY SOCIETY. Idiopathic pulmonary fibrosis: diagnosis and treatment: International Consensus Statement. Am J Respir Crit Care Med 2000; 161: 646-664.
8. WELLS AU, HIRANI N. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63(Suppl V): v1-v58.
9. CHECANI V, LANDRENEAU RJ, SHAIKH SS Open lung biopsy for diffuse infiltrative lung disease. Ann Thorac Surg 1992; 54: 296-300.
10. TEMES RT, JOSTE NE, ALLEN NL, CROWELL RE, DOX HA, WERNLY JA. The lingula is appropriate site for lung biopsy. Ann Thorac Surg 2000; 69: 1016-1018.
11. SWIGRIS JJ, GOULD MK, WILSON SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005; 127: 284-294.
12. OLSCHEWSKI H, WERNER S. Diagnosis and classification according to the WHO conference on PPH in Evian (1998). In: Olschewski H, Werner S editors. Pulmonary Hypertension. Pathophysiology, diagnosis, treatment and development of a pulmonary-selective therapy. Bremen: UNI-MED 2002; 4: 40-50.
13. CARBONE R, MONTANARO F, GHIO R, MONSELISE A, BAUGHMAN R. Cardiac performance in the prognosis of interstitial lung diseases. Sarcoidosis Vascu Diffuse Lung Dis 2006; 23: 237.
14. CARBONE R, FILIBERTI R, GROSSO M, PAREDI P, PEANO L, CANTALUPI D, VILLA G, MONSELISE A, BOTTINO G, SHAH P. Octreoscan perspectives in sarcoidosis and idiopathic interstitial pneumonia. Eur Rev Med Pharmacol Sci 2003: 7: 97-105.
15. CARBONE RG, MONSELISE A, BOTTINO G. Pulmonary hypertension in interstitial lung disease. In: Baughman RP, Carbone RG, Bottino G. (eds.) Pulmonary Arterial Hypertension and Interstitial Lung Diseases. New York: Springer 2009; pp. 13-50.
16. MARTINEZ FJ. Pulmonary hypertension in idiopathic pulmonary fibrosis. In: Baughman RP, Carbone RG, Bottino G. (eds.) Pulmonary Arterial Hypertension and Interstitial Lung Diseases. New York: Springer 2009; pp. 177-194.
17. FLAHERTY KR, KING TE Jr, RAGHU G, LYNCH JP 3RD, COLBY TV, TRAVIS WD, GROSS BH, KAZEROONI EA, TOEWS GB, LONG Q, MURRAY S, LAMA VN, GAY SE, MARTINEZ FJ. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170: 904-910.
18. GROSS TJ, HUNNINGHAKE GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517-525.
19. RAGHU G, WEYCKER D, EDELSBERG J, BRADFORD WZ, OSTER G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
20. MARTINEZ FJ. Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia. Proc Am Thorac Soc 2006; 3: 81-95. (Pubitemid 43304383)
21. GREENE KE, KING TE Jr, KUROKI Y, BUCHER-BARTELSON B, HUNNINGHAKE GW, NEWMAN LS, NAGAE H, MASON RJ. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 2002; 19: 439-446.
22. BAUMGARTNER KB, SAMET JM, STIDLEY CA, COLBY TV, WALDRON JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997, 155: 242-248
23. LETTIERI CJ, NATHAN SD, BARNETT SD, AHMAD S, SHORR AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
24. NADROUS IIF PELLIKKA PA, KROWKA MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488-493.
25. HAMADA K, NAGAI S, TANAKA S, HANDA T, SHIGEMATSU M, NAGAO T, MISHIMA M, KITAICHI M, IZUMI T. Significance of pulmonary arterial and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656.
26. MCQUILLAN BM, PICARD MH, LEAVITT M, WEYMAN AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797-2802.
27. RYU JH, KROWKA MJ, PELLIKKA PA, SWANSON KL, MCGOON MD. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 2007; 82: 342-350. (Pubitemid 46348935)
28. ARCASOY SM, CHRISTIE JD, FERRARI VA, SUTTON MS, ZISMAN DA, BLUMENTHAL NP, POCHETTINO A, KOTLOFF RM. Ecocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167: 735-740.